BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents - Pharmaceutical Technology

The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop. The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop. NVIDIA Healthcare vice president Kimberly Powell announced the BioNeMo toolkit to attendees at the 2026 BIO International Convention in San Diego. Credit: Frankie Fattorini/GlobalData NVIDIA has unveiled the BioNeMo agent toolkit, a package of tools for life sciences R&D designed specifically for use by artificial intelligence (AI) agents. “The $300bn life sciences R&D industry…

Source: Pharmaceutical Technology